Related Experiment Videos
Immunologic and virologic markers determining progression to AIDS
P T Schellekens1, M Koot, M T Roos
1Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Summary
Predicting acquired immunodeficiency syndrome (AIDS) progression in human immunodeficiency virus type 1 (HIV-1) infection requires more than CD4+ cell counts. Additional markers like CD4+ decline rate, T-cell reactivity, and HIV phenotype offer crucial insights.
Area of Science:
- Immunology
- Virology
- Clinical Medicine
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection causes severe immunodeficiency through CD4+ T-helper cell depletion.
- CD4+ cell count predicts acquired immunodeficiency syndrome (AIDS) progression in asymptomatic individuals.
- Clinical progression varies among individuals with similar CD4+ cell counts, necessitating additional predictive markers.
Purpose of the Study:
- To review additional markers for predicting disease progression in HIV-1 infection.
- To explore the clinical importance of markers beyond CD4+ cell counts.
- To gain insight into immunopathologic mechanisms of AIDS development.
Main Methods:
- Review of existing literature on HIV-1 progression markers.
- Discussion of three specific markers: rate of CD4+ cell decline, T-cell reactivity, and HIV biological phenotype.
- Analysis of the utility of these markers as independent predictors.
Main Results:
- The rate of CD4+ cell decline is a significant predictor of HIV-1 progression.
- T-cell reactivity provides valuable information on immune status and disease progression.
- HIV biological phenotype influences the rate of disease progression.
- These markers offer insights into the immunopathogenesis of AIDS.
Conclusions:
- Additional markers beyond CD4+ cell counts are crucial for predicting HIV-1/AIDS progression.
- The rate of CD4+ cell decline, T-cell reactivity, and HIV phenotype are important prognostic indicators.
- Understanding these markers enhances our knowledge of AIDS pathogenesis and informs clinical management.